Twist Bioscience Corp (TWST)
15.03
-1.25 (-7.68%)
USD |
NASDAQ |
Mar 28, 14:12
Twist Bioscience Debt to Equity Ratio: 0.00 for Dec. 31, 2022
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0027 |
| June 30, 2021 | 0.0039 |
| March 31, 2021 | 0.0052 |
| December 31, 2020 | 0.0062 |
| September 30, 2020 | 0.0141 |
| June 30, 2020 | 0.0158 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0237 |
| December 31, 2019 | 0.0679 |
| September 30, 2019 | 0.0508 |
| June 30, 2019 | 0.048 |
| March 31, 2019 | 0.0793 |
| December 31, 2018 | 0.0711 |
| September 30, 2018 | -0.0482 |
| June 30, 2018 | 0.0989 |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -0.0686 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0482
Minimum
Sep 2018
0.0989
Maximum
Jun 2018
0.0231
Average
0.0062
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.4506 |
| Asensus Surgical Inc | 0.00 |
| Ra Medical Systems Inc | -- |
| Retractable Technologies Inc | 0.0173 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 909.97M |
| Total Liabilities (Quarterly) | 163.64M |
| Shareholders Equity (Quarterly) | 746.32M |
| Current Ratio | 6.463 |
| Net Debt Paydown Yield | 0.02% |